Masimo Corporation Cash Flow Conversion Efficiency
Masimo Corporation cash flow conversion efficiency. Based on the latest financial reports, Masimo Corporation (MASI) has a cash flow conversion efficiency ratio of 0.084x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($60.50 Million) by net assets ($721.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Masimo Corporation (1998–2025)
Cash flow conversion efficiency of Masimo Corporation from 1998 to 2025. This chart illustrates how Masimo Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Masimo Corporation (MASI) stock price for real-time trading data and today's change.
Masimo Corporation Cash Flow Conversion Ratio Explained
Masimo Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Masimo Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Masimo Corporation ranked by their cash flow conversion efficiency. Also see MASI market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Huolinhe Opencut Coal Industry Corp Ltd of Inner Mongolia
SHE:002128
|
0.096x |
|
Hyundai Glovis
KO:086280
|
0.028x |
|
Sichuan Kelun Pharmaceutical Co Ltd
SHE:002422
|
0.018x |
|
Ambuja Cements Limited
NSE:AMBUJACEM
|
0.020x |
|
Empresas Copec S.A.
SN:COPEC
|
0.017x |
|
Chart Industries Inc
NYSE:GTLS
|
0.035x |
|
Toro Co
NYSE:TTC
|
0.018x |
|
China Zheshang Bank Co Ltd
SHG:601916
|
-0.430x |
Annual Cash Flow Conversion Efficiency for Masimo Corporation (1998–2025)
The table below shows the annual cash flow conversion efficiency of Masimo Corporation from 1998 to 2025. Review Masimo Corporation free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $721.20 Million | $217.80 Million | 0.302x | +61.75% |
| 2024-12-31 | $1.05 Billion | $196.40 Million | 0.187x | +170.80% |
| 2023-12-31 | $1.36 Billion | $94.10 Million | 0.069x | +213.99% |
| 2022-12-31 | $1.34 Billion | $29.40 Million | 0.022x | -87.14% |
| 2021-12-31 | $1.55 Billion | $264.60 Million | 0.171x | +13.82% |
| 2020-12-31 | $1.41 Billion | $211.10 Million | 0.150x | -20.98% |
| 2019-12-31 | $1.17 Billion | $221.64 Million | 0.190x | -23.22% |
| 2018-12-31 | $969.07 Million | $239.53 Million | 0.247x | +207.98% |
| 2017-12-31 | $724.02 Million | $58.11 Million | 0.080x | -89.21% |
| 2016-12-31 | $560.24 Million | $416.84 Million | 0.744x | +79.62% |
| 2015-12-31 | $275.71 Million | $114.21 Million | 0.414x | +33.54% |
| 2014-12-31 | $307.74 Million | $95.46 Million | 0.310x | +86.40% |
| 2013-12-31 | $326.40 Million | $54.32 Million | 0.166x | -39.19% |
| 2012-12-31 | $275.67 Million | $75.43 Million | 0.274x | -3.08% |
| 2011-12-31 | $279.67 Million | $78.96 Million | 0.282x | +6.43% |
| 2010-12-31 | $230.04 Million | $61.02 Million | 0.265x | +63.07% |
| 2009-12-31 | $289.69 Million | $47.12 Million | 0.163x | -54.33% |
| 2008-12-31 | $219.50 Million | $78.18 Million | 0.356x | +85.44% |
| 2007-12-31 | $150.07 Million | $28.82 Million | 0.192x | -94.23% |
| 2006-12-31 | $56.96 Million | $189.63 Million | 3.329x | +7510.61% |
| 2005-12-31 | $-101.08 Million | $4.54 Million | -0.045x | +93.30% |
| 1999-12-31 | $19.10 Million | $-12.80 Million | -0.670x | -26.30% |
| 1998-12-31 | $14.70 Million | $-7.80 Million | -0.531x | -- |
About Masimo Corporation
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET pla… Read more